A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.
Request a free trial